dinona

Exclusive license to develop, market and sell Leukotuximab in China and 13 foreign countries

aurinia

Exclusive import, manufacturing and distribution rights to all transplant and autoimmune-related indications of voclosporin in China

pharmabcine

Exclusive licensing agreement to develop, manufacture and market tanibirumab in the greater China region, Thailand, Russia and Brazil, and DIG-KT in China, Hong Kong, Macau, Taiwan and Korea

apexigen

Develop and conduct clinical trials to obtain CFDA approval, manufacture, sell, market and distribute anti-TNF α

selecta

Acquired worldwide development, manufacturing and distribution rights, exclusive of Taiwan, of pegsiticase for all indications from EnzymeRx LLC

Granted an exclusive license to Selecta Biosciences, Inc to develop, commercialize and sell pegsiticase worldwide, excluding China, Hong Kong, Macau, Taiwan and Japan

ascentage

Exclusive right to develop and commercialize Bcl-2/xL inhibitor and IAP inhibitor in China

jenkem

Exclusive license to develop, manufacture and market PEG-Irinotecan in China

shandong

Technology transfer agreement for us to carry out the clinical trials and apply for approval for manufacturing colestilan

simm

Patents transfer agreement to conduct clinical trials and to market and sell DJ5